FEI 3002808225 of Bachem Sa | GDUFA | Fees | Self Identification | PharmaCompass.com

Please Wait

Applying Filters...

Bachem AG

Bachem AG

VIRTUAL BOOTH, Contact Details

DIGITAL CONTENT

56 Corporate Content #SupplierSpotlight, 5 Data Compilation #PharmaFlow, 139 News #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

34 All APIs, 17 USDMF, 8 CEP/COS, 9 JDMF, 9 KDMF, 16 NDC API, 2 VMF, 22 Listed APIs

KEY PRODUCTS

Atosiban, Buserelin Acetate, Etomidate, Glucagon, Glucagon Hydrochloride, Gonadorelin, Gonadorelin Acetate, Gonadorelin Hydrochloride, Goserelin Acetate, Leuprolide Acetate, Octreotide Acetate, Propofol, Somatostatin, Tetracosactide, Triptorelin Acetate, Triptorelin Pamoate

SERVICES

API Manufacturing, API & Drug Product Development

API Manufacturing
API & Drug Product Development
- 3 API Development

KEY SERVICES

Custom Peptide Synthesis, CMO for Peptide & Oligonucleotide APIs

INSPECTIONS & REGISTRATIONS

56 FDA, 3 EDQM, 5 GDUFA, 9 Others

Xls

Filters

Filters

FILTER :

filter Registrant Name Reset all filters

1 All

01 1BACHEM SA

filter Facility Name Reset all filters

filter API Manufacture Reset all filters

List of Suppliers

Supplier Virtual Booth

price-trend

01

GDUFA fees paid

USA

Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.

Paid in : 2024

API Manufacturer : API MANUFACTURE

FDF Manufacturer :

Facility Name : BACHEM SA

Business Address : Succursale de Vionnaz Route ...

FEI Number : 3002808225

Country : Switzerland

Paid in : 2024

Bachem company banner

Product
Web Link

Stock Recap
#PipelineProspector

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.